Intuitive Surgical, Inc. (NASDAQ:ISRG – Free Report) – Investment analysts at Leerink Partnrs dropped their FY2024 earnings per share estimates for shares of Intuitive Surgical in a research note issued to investors on Monday, November 25th. Leerink Partnrs analyst M. Kratky now forecasts that the medical equipment provider will post earnings of $5.39 per share for the year, down from their previous forecast of $5.41. The consensus estimate for Intuitive Surgical’s current full-year earnings is $5.45 per share.
Several other equities research analysts have also weighed in on ISRG. BTIG Research increased their target price on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a research report on Tuesday. Mizuho raised their target price on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Piper Sandler reissued an “overweight” rating and issued a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. JPMorgan Chase & Co. increased their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, Oppenheimer reissued a “market perform” rating on shares of Intuitive Surgical in a research note on Friday, October 18th. One analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have assigned a buy rating to the company’s stock. Based on data from MarketBeat.com, Intuitive Surgical currently has an average rating of “Moderate Buy” and a consensus target price of $526.06.
Intuitive Surgical Trading Down 0.7 %
ISRG stock opened at $538.55 on Wednesday. The firm has a market cap of $191.82 billion, a P/E ratio of 86.58, a P/E/G ratio of 5.28 and a beta of 1.39. Intuitive Surgical has a 12-month low of $304.50 and a 12-month high of $552.00. The stock’s 50 day simple moving average is $507.94 and its 200 day simple moving average is $466.79.
Intuitive Surgical (NASDAQ:ISRG – Get Free Report) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion during the quarter, compared to analysts’ expectations of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%.
Insider Buying and Selling at Intuitive Surgical
In other Intuitive Surgical news, Director Amy L. Ladd sold 450 shares of the business’s stock in a transaction on Friday, September 13th. The stock was sold at an average price of $490.28, for a total value of $220,626.00. Following the transaction, the director now owns 821 shares of the company’s stock, valued at approximately $402,519.88. The trade was a 35.41 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, SVP Mark Brosius sold 2,128 shares of the company’s stock in a transaction on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,095,920.00. Following the transaction, the senior vice president now directly owns 273 shares in the company, valued at $140,595. This trade represents a 88.63 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 50,459 shares of company stock worth $26,080,251 over the last three months. Company insiders own 0.80% of the company’s stock.
Hedge Funds Weigh In On Intuitive Surgical
Several large investors have recently made changes to their positions in ISRG. Creekmur Asset Management LLC increased its holdings in Intuitive Surgical by 200.0% in the first quarter. Creekmur Asset Management LLC now owns 63 shares of the medical equipment provider’s stock valued at $25,000 after purchasing an additional 42 shares during the last quarter. Ridgewood Investments LLC bought a new stake in shares of Intuitive Surgical in the second quarter worth about $26,000. Godsey & Gibb Inc. increased its holdings in shares of Intuitive Surgical by 140.0% in the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider’s stock worth $29,000 after acquiring an additional 35 shares in the last quarter. LRI Investments LLC bought a new stake in shares of Intuitive Surgical in the first quarter worth about $30,000. Finally, LGT Financial Advisors LLC increased its holdings in shares of Intuitive Surgical by 415.4% in the second quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider’s stock worth $30,000 after acquiring an additional 54 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.
About Intuitive Surgical
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Featured Stories
- Five stocks we like better than Intuitive Surgical
- Best Aerospace Stocks Investing
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Bank Stocks – Best Bank Stocks to Invest In
- 2 Generic Drug Stocks Ready to Surge in 2025
Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.